ckd
Showing 1 - 25 of 45
Children With Chronic Kidney Disease
Not yet recruiting
- CKD
- Hematological Disease
- (no location specified)
Nov 20, 2023
Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)
Not yet recruiting
- Diabetes Mellitus Type 2 With Proteinuria
- +12 more
- Empagliflozin 10 MG
- +6 more
- (no location specified)
Oct 17, 2023
The Living With a Long-Term Condition Study
Recruiting
- Asthma
- +44 more
- Living with LTC Questionnaire
-
London, United KingdomKing's College London
Oct 10, 2023
Non-alcoholic Fatty Liver Disease in Chronic Kidney Disease in
Not yet recruiting
- CKD
- NAFLD
- (no location specified)
Aug 22, 2023
Kidney Diseases, Metabolic Acidosis, Renal Insufficiency Trial in Hillerød (Low PRAL)
Active, not recruiting
- Kidney Diseases
- +4 more
- Low PRAL
-
Hillerød, DenmarkNordshjaellands Hospital
Jul 23, 2023
Overweight or Obesity, CKD, Type 2 Diabetes Trial in Worldwide (LY3437943, Placebo)
Not yet recruiting
- Overweight or Obesity
- +2 more
- LY3437943
- Placebo
-
Canoga Park, California
- +19 more
Jun 30, 2023
Safety Evaluation of GamCath HighFlow Dolphin Protect Catheter
Enrolling by invitation
- AKI - Acute Kidney Injury
- +3 more
- Vascular access catheter to support dialysis or CRRT
-
Lublin, Poland
- +1 more
Jun 2, 2023
CKD Trial in Nanjing (Fecal Microbiota Transplantation, Standard of Care for Chronic Kidney Disease)
Recruiting
- CKD
- Fecal Microbiota Transplantation
- Standard of Care for Chronic Kidney Disease
-
Nanjing, Jiangsu, Chinathe Second Affiliated of Nanjing Medical University
Apr 20, 2023
Kidney Diseases, Metabolic Acidosis, Renal Insufficiency Trial in Hillerød (Low PRAL)
Recruiting
- Kidney Diseases
- +4 more
- Low PRAL
-
Hillerød, DenmarkNordshjaellands Hospital
Mar 27, 2023
Chronic Kidney Disease, CKD, Cardiac Disease Trial in Worldwide (Placebo, Ravulizumab)
Not yet recruiting
- Chronic Kidney Disease
- +3 more
- Placebo
- Ravulizumab
-
San Francisco, California
- +96 more
Feb 27, 2023
AKI - Acute Kidney Injury, Biomarkers, Transition to CKD Trial in Mexico City (Dapagliflozin)
Recruiting
- AKI - Acute Kidney Injury
- +3 more
-
Mexico City, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Jan 26, 2023
CKD, Type 2 Diabetes Trial
Not yet recruiting
- CKD
- Type 2 Diabetes
- (no location specified)
Jan 11, 2023
Heart Diseases, CKD, Diabetes Trial (Motivational tteaching)
Not yet recruiting
- Heart Diseases
- +6 more
- Motivational tteaching
- (no location specified)
Dec 7, 2022
Sarcopenia and Cardiovascular Disease in Chronic Kidney Disease
Completed
- Sarcopenia
- +2 more
-
Shanghai, Shanghai, ChinaBaoshan Site of Shanghai Renji Hospital, Shanghai Jiaotong Unive
Jul 28, 2022
Fibroblast Growth Factor 23, Anemia, CKD Trial in Córdoba
Active, not recruiting
- Fibroblast Growth Factor 23
- +2 more
-
Córdoba, SpainHospital Universitario Reina Sofia
Apr 27, 2022
CKD, Diabetes, Type 2, Hyperkalemia Trial in London (Sodium Zirconium Cyclosilicate, Placebo)
Not yet recruiting
- CKD
- +2 more
- Sodium Zirconium Cyclosilicate
- Placebo
-
London, Uk, United KingdomKieran Mccafferty
Mar 17, 2022
CKD Trial in New York (Ambulatory Supportive Care)
Recruiting
- CKD
- Ambulatory Supportive Care
-
New York, New YorkNYC Health + Hospitals / Bellevue
Feb 23, 2022
Thyroid , Parathyroid Hormones and eGFR in CKD Assiut
Not yet recruiting
- Thyroid
- +2 more
- DEXA scan
- (no location specified)
Feb 19, 2022
CKD, Diabetic Kidney Disease, Type 2 Diabetes in Obese Trial in Danville, Wilkes-Barre (Semaglutide 2 mg/1.5 ml (1.34 mg/ml),
Recruiting
- CKD
- +4 more
- Semaglutide 2 mg/1.5 ml (1.34 mg/ml), prefilled pen-injector for subcutaneous injection solution
- Placebo 1.5 ml, prefilled pen-injector for subcutaneous injection solution
-
Danville, Pennsylvania
- +1 more
Feb 3, 2022
Covid19, Comorbidities and Coexisting Conditions, Risk Factor, Cardiovascular Trial in Moscow
Completed
- Covid19
- +8 more
-
Moscow, Russian FederationEurasian Association of Therapists
Feb 1, 2022
Assessment in CKD and Kidney Transplanted Patients Following
Recruiting
- CKD
- +5 more
- FMD
- +6 more
-
Iasi, RomaniaDr CI Parhon Clinical Hospital of Iasi
Jan 5, 2022
Antibody After COVID-19 Vaccination
Completed
- Covid19
- +4 more
- COVID vaccine
-
Bangkok, ThailandFaculty of Medicine,Vajira Hospital
Jan 10, 2022
StatStrip A Glucose/Creatinine Meter System Lay User Study
Recruiting
- Diabete Mellitus
- +2 more
- Glucose, Creatinine
-
Miami Gardens, FloridaExcellence Medical Research
Dec 21, 2021
HCC, CKD Trial in Seoul (low dose CT contrast media, Standard dose CT contrast media)
Active, not recruiting
- HCC
- CKD
- low dose CT contrast media
- Standard dose CT contrast media
-
Seoul, Korea, Republic ofSeoul National University Hospital
Dec 16, 2021